| Michelle L Gorman Mcnerney, MD | |
|
8100 Northland Dr, Bloomington, MN 55431-4800 | |
| (952) 831-8742 | |
| Not Available |
| Full Name | Michelle L Gorman Mcnerney |
|---|---|
| Gender | Female |
| Speciality | Sports Medicine |
| Experience | 20 Years |
| Location | 8100 Northland Dr, Bloomington, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396716304 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 47923 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Park Nicollet Methodist Hospital | Saint louis park, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tria Orthopaedic Center Llc | 3173570561 | 367 |
News Archive
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, "Co-administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer" in Australia and "Selectively Depolymerized Galactomannan Polysaccharide" in the United States.
A new study finds that effective new hepatitis C drugs are so expensive the state of Rhode Island would have to spend almost twice its entire prison health budget to treat all its chronically infected inmates.
Like a juggler keeping multiple plates in the air, a surgeon in academic medicine must balance research and medical training with outstanding patient care. Charles Bellows, MD, FACS, relishes the challenge. Dr. Bellows, a University of New Mexico Professor of General Surgery, recently assumed the role of Chief of the Division of General Surgery in the Department of Surgery at the UNM School of Medicine.
A team of researchers from Imperial College London has conducted a study aimed at calculating a reasonably accurate case fatality ratio and infection fatality ratio, which is based on Chinese data as well as international reports. The research is published on the pre-print server MedRxiv.
A new research funding agreement between the Juvenile Diabetes Research Foundation and Sernova, a clinical-stage regenerative medicine biotech, aims to address people with severe type 1 diabetes (T1D) who are hypoglycemia unaware, a condition in which a person with diabetes does not experience the usual early warning symptoms of hypoglycemia (low blood sugar) following an insulin injection.
› Verified 3 days ago
| Entity Name | Park Nicollet Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780621904 PECOS PAC ID: 7911819438 Enrollment ID: O20031104000046 |
News Archive
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, "Co-administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer" in Australia and "Selectively Depolymerized Galactomannan Polysaccharide" in the United States.
A new study finds that effective new hepatitis C drugs are so expensive the state of Rhode Island would have to spend almost twice its entire prison health budget to treat all its chronically infected inmates.
Like a juggler keeping multiple plates in the air, a surgeon in academic medicine must balance research and medical training with outstanding patient care. Charles Bellows, MD, FACS, relishes the challenge. Dr. Bellows, a University of New Mexico Professor of General Surgery, recently assumed the role of Chief of the Division of General Surgery in the Department of Surgery at the UNM School of Medicine.
A team of researchers from Imperial College London has conducted a study aimed at calculating a reasonably accurate case fatality ratio and infection fatality ratio, which is based on Chinese data as well as international reports. The research is published on the pre-print server MedRxiv.
A new research funding agreement between the Juvenile Diabetes Research Foundation and Sernova, a clinical-stage regenerative medicine biotech, aims to address people with severe type 1 diabetes (T1D) who are hypoglycemia unaware, a condition in which a person with diabetes does not experience the usual early warning symptoms of hypoglycemia (low blood sugar) following an insulin injection.
› Verified 3 days ago
| Entity Name | Tria Orthopaedic Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518273085 PECOS PAC ID: 3173570561 Enrollment ID: O20110310000999 |
News Archive
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, "Co-administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer" in Australia and "Selectively Depolymerized Galactomannan Polysaccharide" in the United States.
A new study finds that effective new hepatitis C drugs are so expensive the state of Rhode Island would have to spend almost twice its entire prison health budget to treat all its chronically infected inmates.
Like a juggler keeping multiple plates in the air, a surgeon in academic medicine must balance research and medical training with outstanding patient care. Charles Bellows, MD, FACS, relishes the challenge. Dr. Bellows, a University of New Mexico Professor of General Surgery, recently assumed the role of Chief of the Division of General Surgery in the Department of Surgery at the UNM School of Medicine.
A team of researchers from Imperial College London has conducted a study aimed at calculating a reasonably accurate case fatality ratio and infection fatality ratio, which is based on Chinese data as well as international reports. The research is published on the pre-print server MedRxiv.
A new research funding agreement between the Juvenile Diabetes Research Foundation and Sernova, a clinical-stage regenerative medicine biotech, aims to address people with severe type 1 diabetes (T1D) who are hypoglycemia unaware, a condition in which a person with diabetes does not experience the usual early warning symptoms of hypoglycemia (low blood sugar) following an insulin injection.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michelle L Gorman Mcnerney, MD 8170 33rd Ave S, P.o. Box 1309 Mail Stop 21110q, Minneapolis, MN 55425-4516 Ph: () - | Michelle L Gorman Mcnerney, MD 8100 Northland Dr, Bloomington, MN 55431-4800 Ph: (952) 831-8742 |
News Archive
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, "Co-administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer" in Australia and "Selectively Depolymerized Galactomannan Polysaccharide" in the United States.
A new study finds that effective new hepatitis C drugs are so expensive the state of Rhode Island would have to spend almost twice its entire prison health budget to treat all its chronically infected inmates.
Like a juggler keeping multiple plates in the air, a surgeon in academic medicine must balance research and medical training with outstanding patient care. Charles Bellows, MD, FACS, relishes the challenge. Dr. Bellows, a University of New Mexico Professor of General Surgery, recently assumed the role of Chief of the Division of General Surgery in the Department of Surgery at the UNM School of Medicine.
A team of researchers from Imperial College London has conducted a study aimed at calculating a reasonably accurate case fatality ratio and infection fatality ratio, which is based on Chinese data as well as international reports. The research is published on the pre-print server MedRxiv.
A new research funding agreement between the Juvenile Diabetes Research Foundation and Sernova, a clinical-stage regenerative medicine biotech, aims to address people with severe type 1 diabetes (T1D) who are hypoglycemia unaware, a condition in which a person with diabetes does not experience the usual early warning symptoms of hypoglycemia (low blood sugar) following an insulin injection.
› Verified 3 days ago
Dr. Karen Lawson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8166 Utah Ave S, Bloomington, MN 55438 Phone: 612-369-0393 | |
Dr. Samuel A.l. Bugbee, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8100 Northland Dr, Bloomington, MN 55431 Phone: 952-831-8742 Fax: 952-831-1626 | |
Christine Ann Morley, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5320 Hyland Greens Dr, Bloomington, MN 55437 Phone: 952-993-2400 | |
James K Struve, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 7901 Xerxes Ave S Ste 116, Bloomington, MN 55431 Phone: 952-888-2024 Fax: 952-888-3985 | |
Mckayla Schmitt, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8100 Northland Dr, Bloomington, MN 55431 Phone: 952-831-8742 | |
John Alexander Noll, D.O Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8100 Northland Dr, Bloomington, MN 55431 Phone: 952-831-8742 | |
Dr. Joseph Andrew Nelson, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 8053 E Bloomington Fwy Ste 450, Bloomington, MN 55420 Phone: 612-376-7708 |